Report Detail
Global Patient Recruitment for Clinical Trials Market Growth (Status and Outlook) 2022-2028
- RnM4432005 |
- 06 May, 2022 |
- Global |
- 124 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Patient Recruitment for Clinical Trials will have significant change from previous year. According to our (LP Information) latest study, the global Patient Recruitment for Clinical Trials market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Patient Recruitment for Clinical Trials market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Patient Recruitment for Clinical Trials market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Patient Recruitment for Clinical Trials market, reaching US$ million by the year 2028. As for the Europe Patient Recruitment for Clinical Trials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Patient Recruitment for Clinical Trials players cover Antidote, Clara Health, Clariness, and BBK Worldwide, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Patient Recruitment for Clinical Trials market by product type, application, key players and key regions and countries.
Segmentation by phase: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Phase I
Phase II
Phase III
Phase IV
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Endocrine
Anti-Infective
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Antidote
Clara Health
Clariness
BBK Worldwide
Worldwide Clinical Trials
Clinical Site Services (CCSi)
IQVIA
PPD Inc
Veristat
Elligo Health Research
AutoCruitment
Clinical Connection
Biorasi
Curavit Clinical Research
PatientEvolution
Praxis
MMG
Science37
StudyKIK
Global AES
TrialSpark
WCG ThreeWire
Trialfacts
Shanghai Jsure
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Patient Recruitment for Clinical Trials Market Size 2017-2028
- 2.1.2 Patient Recruitment for Clinical Trials Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Patient Recruitment for Clinical Trials Segment by Phase
- 2.2.1 Phase I
- 2.2.2 Phase II
- 2.2.3 Phase III
- 2.2.4 Phase IV
- 2.3 Patient Recruitment for Clinical Trials Market Size by Phase
- 2.3.1 Patient Recruitment for Clinical Trials Market Size CAGR by Phase (2017 VS 2022 VS 2028)
- 2.3.2 Global Patient Recruitment for Clinical Trials Market Size Market Share by Phase (2017-2022)
- 2.4 Patient Recruitment for Clinical Trials Segment by Application
- 2.4.1 Respiratory Diseases
- 2.4.2 Pain and Anesthesia
- 2.4.3 Oncology
- 2.4.4 Central Nervous System
- 2.4.5 Cardiovascular
- 2.4.6 Endocrine
- 2.4.7 Anti-Infective
- 2.4.8 Others
- 2.5 Patient Recruitment for Clinical Trials Market Size by Application
- 2.5.1 Patient Recruitment for Clinical Trials Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Patient Recruitment for Clinical Trials Market Size Market Share by Application (2017-2022)
3 Patient Recruitment for Clinical Trials Market Size by Player
- 3.1 Patient Recruitment for Clinical Trials Market Size Market Share by Players
- 3.1.1 Global Patient Recruitment for Clinical Trials Revenue by Players (2020-2022)
- 3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Players (2020-2022)
- 3.2 Global Patient Recruitment for Clinical Trials Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Patient Recruitment for Clinical Trials by Regions
- 4.1 Patient Recruitment for Clinical Trials Market Size by Regions (2017-2022)
- 4.2 Americas Patient Recruitment for Clinical Trials Market Size Growth (2017-2022)
- 4.3 APAC Patient Recruitment for Clinical Trials Market Size Growth (2017-2022)
- 4.4 Europe Patient Recruitment for Clinical Trials Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Patient Recruitment for Clinical Trials Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Patient Recruitment for Clinical Trials Market Size by Country (2017-2022)
- 5.2 Americas Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
- 5.3 Americas Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Patient Recruitment for Clinical Trials Market Size by Region (2017-2022)
- 6.2 APAC Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
- 6.3 APAC Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Patient Recruitment for Clinical Trials by Country (2017-2022)
- 7.2 Europe Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
- 7.3 Europe Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Patient Recruitment for Clinical Trials by Region (2017-2022)
- 8.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Phase (2017-2022)
- 8.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Patient Recruitment for Clinical Trials Market Forecast
- 10.1 Global Patient Recruitment for Clinical Trials Forecast by Regions (2023-2028)
- 10.1.1 Global Patient Recruitment for Clinical Trials Forecast by Regions (2023-2028)
- 10.1.2 Americas Patient Recruitment for Clinical Trials Forecast
- 10.1.3 APAC Patient Recruitment for Clinical Trials Forecast
- 10.1.4 Europe Patient Recruitment for Clinical Trials Forecast
- 10.1.5 Middle East & Africa Patient Recruitment for Clinical Trials Forecast
- 10.2 Americas Patient Recruitment for Clinical Trials Forecast by Country (2023-2028)
- 10.2.1 United States Patient Recruitment for Clinical Trials Market Forecast
- 10.2.2 Canada Patient Recruitment for Clinical Trials Market Forecast
- 10.2.3 Mexico Patient Recruitment for Clinical Trials Market Forecast
- 10.2.4 Brazil Patient Recruitment for Clinical Trials Market Forecast
- 10.3 APAC Patient Recruitment for Clinical Trials Forecast by Region (2023-2028)
- 10.3.1 China Patient Recruitment for Clinical Trials Market Forecast
- 10.3.2 Japan Patient Recruitment for Clinical Trials Market Forecast
- 10.3.3 Korea Patient Recruitment for Clinical Trials Market Forecast
- 10.3.4 Southeast Asia Patient Recruitment for Clinical Trials Market Forecast
- 10.3.5 India Patient Recruitment for Clinical Trials Market Forecast
- 10.3.6 Australia Patient Recruitment for Clinical Trials Market Forecast
- 10.4 Europe Patient Recruitment for Clinical Trials Forecast by Country (2023-2028)
- 10.4.1 Germany Patient Recruitment for Clinical Trials Market Forecast
- 10.4.2 France Patient Recruitment for Clinical Trials Market Forecast
- 10.4.3 UK Patient Recruitment for Clinical Trials Market Forecast
- 10.4.4 Italy Patient Recruitment for Clinical Trials Market Forecast
- 10.4.5 Russia Patient Recruitment for Clinical Trials Market Forecast
- 10.5 Middle East & Africa Patient Recruitment for Clinical Trials Forecast by Region (2023-2028)
- 10.5.1 Egypt Patient Recruitment for Clinical Trials Market Forecast
- 10.5.2 South Africa Patient Recruitment for Clinical Trials Market Forecast
- 10.5.3 Israel Patient Recruitment for Clinical Trials Market Forecast
- 10.5.4 Turkey Patient Recruitment for Clinical Trials Market Forecast
- 10.5.5 GCC Countries Patient Recruitment for Clinical Trials Market Forecast
- 10.6 Global Patient Recruitment for Clinical Trials Forecast by Phase (2023-2028)
- 10.7 Global Patient Recruitment for Clinical Trials Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Antidote
- 11.1.1 Antidote Company Information
- 11.1.2 Antidote Patient Recruitment for Clinical Trials Product Offered
- 11.1.3 Antidote Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Antidote Main Business Overview
- 11.1.5 Antidote Latest Developments
- 11.2 Clara Health
- 11.2.1 Clara Health Company Information
- 11.2.2 Clara Health Patient Recruitment for Clinical Trials Product Offered
- 11.2.3 Clara Health Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Clara Health Main Business Overview
- 11.2.5 Clara Health Latest Developments
- 11.3 Clariness
- 11.3.1 Clariness Company Information
- 11.3.2 Clariness Patient Recruitment for Clinical Trials Product Offered
- 11.3.3 Clariness Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Clariness Main Business Overview
- 11.3.5 Clariness Latest Developments
- 11.4 BBK Worldwide
- 11.4.1 BBK Worldwide Company Information
- 11.4.2 BBK Worldwide Patient Recruitment for Clinical Trials Product Offered
- 11.4.3 BBK Worldwide Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 BBK Worldwide Main Business Overview
- 11.4.5 BBK Worldwide Latest Developments
- 11.5 Worldwide Clinical Trials
- 11.5.1 Worldwide Clinical Trials Company Information
- 11.5.2 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Product Offered
- 11.5.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Worldwide Clinical Trials Main Business Overview
- 11.5.5 Worldwide Clinical Trials Latest Developments
- 11.6 Clinical Site Services (CCSi)
- 11.6.1 Clinical Site Services (CCSi) Company Information
- 11.6.2 Clinical Site Services (CCSi) Patient Recruitment for Clinical Trials Product Offered
- 11.6.3 Clinical Site Services (CCSi) Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Clinical Site Services (CCSi) Main Business Overview
- 11.6.5 Clinical Site Services (CCSi) Latest Developments
- 11.7 IQVIA
- 11.7.1 IQVIA Company Information
- 11.7.2 IQVIA Patient Recruitment for Clinical Trials Product Offered
- 11.7.3 IQVIA Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 IQVIA Main Business Overview
- 11.7.5 IQVIA Latest Developments
- 11.8 PPD Inc
- 11.8.1 PPD Inc Company Information
- 11.8.2 PPD Inc Patient Recruitment for Clinical Trials Product Offered
- 11.8.3 PPD Inc Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 PPD Inc Main Business Overview
- 11.8.5 PPD Inc Latest Developments
- 11.9 Veristat
- 11.9.1 Veristat Company Information
- 11.9.2 Veristat Patient Recruitment for Clinical Trials Product Offered
- 11.9.3 Veristat Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Veristat Main Business Overview
- 11.9.5 Veristat Latest Developments
- 11.10 Elligo Health Research
- 11.10.1 Elligo Health Research Company Information
- 11.10.2 Elligo Health Research Patient Recruitment for Clinical Trials Product Offered
- 11.10.3 Elligo Health Research Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Elligo Health Research Main Business Overview
- 11.10.5 Elligo Health Research Latest Developments
- 11.11 AutoCruitment
- 11.11.1 AutoCruitment Company Information
- 11.11.2 AutoCruitment Patient Recruitment for Clinical Trials Product Offered
- 11.11.3 AutoCruitment Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 AutoCruitment Main Business Overview
- 11.11.5 AutoCruitment Latest Developments
- 11.12 Clinical Connection
- 11.12.1 Clinical Connection Company Information
- 11.12.2 Clinical Connection Patient Recruitment for Clinical Trials Product Offered
- 11.12.3 Clinical Connection Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Clinical Connection Main Business Overview
- 11.12.5 Clinical Connection Latest Developments
- 11.13 Biorasi
- 11.13.1 Biorasi Company Information
- 11.13.2 Biorasi Patient Recruitment for Clinical Trials Product Offered
- 11.13.3 Biorasi Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Biorasi Main Business Overview
- 11.13.5 Biorasi Latest Developments
- 11.14 Curavit Clinical Research
- 11.14.1 Curavit Clinical Research Company Information
- 11.14.2 Curavit Clinical Research Patient Recruitment for Clinical Trials Product Offered
- 11.14.3 Curavit Clinical Research Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Curavit Clinical Research Main Business Overview
- 11.14.5 Curavit Clinical Research Latest Developments
- 11.15 PatientEvolution
- 11.15.1 PatientEvolution Company Information
- 11.15.2 PatientEvolution Patient Recruitment for Clinical Trials Product Offered
- 11.15.3 PatientEvolution Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 PatientEvolution Main Business Overview
- 11.15.5 PatientEvolution Latest Developments
- 11.16 Praxis
- 11.16.1 Praxis Company Information
- 11.16.2 Praxis Patient Recruitment for Clinical Trials Product Offered
- 11.16.3 Praxis Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Praxis Main Business Overview
- 11.16.5 Praxis Latest Developments
- 11.17 MMG
- 11.17.1 MMG Company Information
- 11.17.2 MMG Patient Recruitment for Clinical Trials Product Offered
- 11.17.3 MMG Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 MMG Main Business Overview
- 11.17.5 MMG Latest Developments
- 11.18 Science37
- 11.18.1 Science37 Company Information
- 11.18.2 Science37 Patient Recruitment for Clinical Trials Product Offered
- 11.18.3 Science37 Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 Science37 Main Business Overview
- 11.18.5 Science37 Latest Developments
- 11.19 StudyKIK
- 11.19.1 StudyKIK Company Information
- 11.19.2 StudyKIK Patient Recruitment for Clinical Trials Product Offered
- 11.19.3 StudyKIK Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 StudyKIK Main Business Overview
- 11.19.5 StudyKIK Latest Developments
- 11.20 Global AES
- 11.20.1 Global AES Company Information
- 11.20.2 Global AES Patient Recruitment for Clinical Trials Product Offered
- 11.20.3 Global AES Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 Global AES Main Business Overview
- 11.20.5 Global AES Latest Developments
- 11.21 TrialSpark
- 11.21.1 TrialSpark Company Information
- 11.21.2 TrialSpark Patient Recruitment for Clinical Trials Product Offered
- 11.21.3 TrialSpark Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.21.4 TrialSpark Main Business Overview
- 11.21.5 TrialSpark Latest Developments
- 11.22 WCG ThreeWire
- 11.22.1 WCG ThreeWire Company Information
- 11.22.2 WCG ThreeWire Patient Recruitment for Clinical Trials Product Offered
- 11.22.3 WCG ThreeWire Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.22.4 WCG ThreeWire Main Business Overview
- 11.22.5 WCG ThreeWire Latest Developments
- 11.23 Trialfacts
- 11.23.1 Trialfacts Company Information
- 11.23.2 Trialfacts Patient Recruitment for Clinical Trials Product Offered
- 11.23.3 Trialfacts Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.23.4 Trialfacts Main Business Overview
- 11.23.5 Trialfacts Latest Developments
- 11.24 Shanghai Jsure
- 11.24.1 Shanghai Jsure Company Information
- 11.24.2 Shanghai Jsure Patient Recruitment for Clinical Trials Product Offered
- 11.24.3 Shanghai Jsure Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2020-2022)
- 11.24.4 Shanghai Jsure Main Business Overview
- 11.24.5 Shanghai Jsure Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Patient Recruitment for Clinical Trials. Industry analysis & Market Report on Patient Recruitment for Clinical Trials is a syndicated market report, published as Global Patient Recruitment for Clinical Trials Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Patient Recruitment for Clinical Trials market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
